Yuichiro� Doki
Impact in
- Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Co-authors
- Masaki Mori (251 shared papers)Makoto Yamasaki (251 shared papers)Shuji Takiguchi (251 shared papers)Hidetoshi Eguchi (251 shared papers)Yukinori Kurokawa (251 shared papers)Hiroshi Miyata (201 shared papers)Kiyokazu Nakajima (251 shared papers)Hideshi Ishii (120 shared papers)
- Journals
- Annals of Surgical Oncology (120 papers)Surgery Today (83 papers)Esophagus (54 papers)British Journal of Cancer (46 papers)Annals of Gastroenterological Surgery (41 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Yuichiro� Doki
1.4k papers receiving 39.9k citations
Yuichiro� Doki's Hit Papers
Peers
Comparison fields: 5 of 177
- Cancer Research 7.7k
- Oncology 10.2k
- Gastroenterology 1.3k
- Surgery 9.9k
- Pulmonary and Respiratory Medicine 6.6k
Countries citing papers authored by Yuichiro� Doki
This map shows the geographic impact of Yuichiro� Doki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro� Doki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro� Doki more than expected).
Fields of papers citing papers by Yuichiro� Doki
This network shows the impact of papers produced by Yuichiro� Doki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro� Doki. The network helps show where Yuichiro� Doki may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuichiro� Doki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.4k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 894 |
| 2 | Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers Hit paper breakdown → | 2016 | 731 |
| 3 | Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs Hit paper breakdown → | 2011 | 625 |
| 4 | 2010 | 539 | |
| 5 | Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma Hit paper breakdown → | 2022 | 461 |
| 6 | 2015 | 438 | |
| 7 | Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial Hit paper breakdown → | 2017 | 322 |
| 8 | 2017 | 318 | |
| 9 | 2011 | 315 | |
| 10 | 2010 | 310 | |
| 11 | Thoracic and cardiovascular surgery in Japan during 2014 Hit paper breakdown → | 2016 | 298 |
| 12 | 2016 | 276 | |
| 13 | 2013 | 262 | |
| 14 | 2009 | 240 | |
| 15 | 2017 | 236 | |
| 16 | 2011 | 224 | |
| 17 | 2011 | 223 | |
| 18 | Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. | 1997 | 212 |
| 19 | 2017 | 196 | |
| 20 | 2014 | 195 |
About Yuichiro� Doki
Yuichiro� Doki is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Gastroenterology, having authored 1.4k papers that have together received 40.5k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (211 papers), Gastric Cancer Management and Outcomes (147 papers), Pancreatic and Hepatic Oncology Research (103 papers), Gastrointestinal Tumor Research and Treatment (64 papers), Esophageal and GI Pathology (59 papers), Colorectal Cancer Surgical Treatments (58 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (52 papers) and Cancer Cells and Metastasis (51 papers). The work is most often cited by research in Cancer Research (7.7k citations), Oncology (10.2k citations), Gastroenterology (1.3k citations), Surgery (9.9k citations) and Pulmonary and Respiratory Medicine (6.6k citations). Yuichiro� Doki has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Masaki Mori, Makoto Yamasaki, Shuji Takiguchi, Hidetoshi Eguchi, Yukinori Kurokawa, Hiroshi Miyata, Kiyokazu Nakajima, Hideshi Ishii, Hirofumi Yamamoto and Tsunekazu Mizushima. Their work appears in journals such as Annals of Surgical Oncology, Surgery Today, Esophagus, British Journal of Cancer and Annals of Gastroenterological Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.